Johnson and Johnson Services, Inc., Arthrex, Inc. and Stryker are Dominating the Global Foot and Ankle Devices Market in 2018

Foot and Ankle Devices Market is projected to register a substantial CAGR of 7.8% in the forecast period of 2019 to 2026. The years considered for study are as mentioned below:

Access Full Report at

Global foot and ankle devices market is a highly concentrated market which includes key players and local players. The market has witnessed increased various strategic developments owing to favourable market scenario. The market has a prominent growth in upcoming years due to increasing incidence of musculoskeletal disorders and growing number of sports injuries and road accidents.

The market has witnessed developments in terms of merger and acquisitions, partnerships or product launches to enhance the product portfolio to meet the rising demand of innovative monitoring technology in foot and ankle devices. For instance, In October 2018, Johnson & Johnson Services, Inc. announced that it has an agreement with Ortho Development Corporation in order to promote KASM Knee Articulating Spacer Mold which is used in curing infections after the knee replacement is going to help the company in retaining their customers and would add the existing knee portfolio by early detection and helping patients.

Johnson & Johnson Services, Inc. is dominating the global foot and ankle devices market. The other key players in the market include Arthrex Inc., Stryker, Zimmer Biomet, Wright Medical Group N.V., Smith & Nephew, Ottobock, JEIL MEDICAL CORPORATION, Acumed LLC, Extremity Medical, Osteotec, Response Ortho, VILEX IN TENNESSEE, INC., Globus Medical, Integra LifeSciences Corporation, Össur Corporate among others.

Johnson & Johnson Services, Inc.

Johnson & Johnson Services, Inc. is a public company which is headquartered in New Jersey, U.S. and was founded in 1886. The company is engaged in the research and development, manufacturing and sale of a wide range of products in the health care field. The company operates through three business segments such as pharmaceutical, medical devices, consumer in which medical devices is the market focused segment. The company has wide range of product category such as access, adjunctive hemostats, energy sealing & dissecting, foot & ankle, hernia mesh & fixation, hip, joint reconstruction, knee, ligation, magnetic spinctor augmentation, microwave ablation, mitek sports medicine, power tools, shoulder, spine, surgical stapling, trauma, uterine & pelvic, vascular access & infection control, wound closure, CMF in which foot & ankle is the market focused category. The company has approx. 130,000 employees.

  • In September 2019, Johnson & Johnson Services, Inc. launched the 3D Printed Implant for the process of portfolio CONDUIT Interbody Platform with EIT Cellular Titanium Technology thereby expanding its offerings to treat deteriorating spine disease. This innovative product is designed in order to mimic natural bone and facilitate spinal fusion. With the launch of this product, Johnson & Johnson is becoming one of the leaders in 3D printing. The CONDUIT Platform with PROTI 360° Family will be represented at NASS as part of DePuy Synthes’ inventive solutions which will fulfill the needs for patients and surgeons in degenerative disc disease, complex cervical procedures and deformity. With the company’s collaboration among DePuy Synthes, Brainlab has an opportunity to work for navigation in the U.S.

The company has its presence in Europe, Asia-Pacific, Middle East & Africa, and Americas. The company has subsidiaries such as Janssen Global Services, LLC (Belgium), Neutrogena (U.S.), DePuy Synthes (U.S.), Ethicon USA, LLC. (U.S.), Janssen Global Services, LLC (Belgium) among others.

Arthrex, Inc.

Arthrex, Inc. is a private company which is headquartered in Florida, U.S. and was founded in 1981. The company is engaged in manufacturing medical devices and in the product development and medical education in orthopedics. The company has various product categories such as shoulder, knee, elbow, hand & wrist, foot & ankle, hip, orthobiologics, imaging and resection in which foot & ankle is the market focused category.

  • In March 2018, Tissue Regenix group has announced the signing of a long-lasting multi-year distribution agreement with Arthrex Inc., a manufacturer of orthopedic surgical technologies by the subsidiary CellRight Technologies (CellRight). CellRight produces orthopedic, spinal and foot and ankle verified osteobiologics that enhances health potential of trauma-and disease-related defects. This development enhances the company’s presence in the market.

The company has its presence in Asia-Pacific, Europe, Middle East and Africa, Latin America, North America. The company has various subsidiaries such as Arthrex GmbH (Germany), Arthrex Limited (U.S.), Arthrex Manufacturing, Inc. (U.S.), iBalance Medical, Inc. (U.S.), Allograft Tissue Systems, Inc. (U.S.) among others.


Stryker is a public company which is headquartered in Michigan, U.S. and was founded incorporated in 1946. The company is engaged in offering products and services in medical and surgical, orthopedics and neurotechnology and spine for enhancing the healthcare sector. Stryker has multiple business segments such as MedSurg, orthopaedics; neurotechnology & spine in which orthopaedics is the market focused segment. The company has various product categories such as Medical and Surgical Equipment, Orthopaedics, Neurotechnology in which orthopaedics is the market focused category. The company has approx. 36,000 employees.

  • In July 2017, Stryker has released a new version of its Hoffmann LRF Hexapod software and hardware. The company provides a specialized method for calculating deformations and limbs by importing patient rays into the program and offers solutions for the repair of deformities and reconstruction. This offers high-level drives rather than side lines that allow equipment easier to access and handle.

The company has wide global presence in Americas, Asia, Europe, Eastern Europe, Middle East & Africa. The company has various subsidiaries such as Physio-Control (U.S.), Invuity (U.S.), Entellus Medical, Inc. (U.S.), Cactus, LLC (U.S.), Stryker (India) Private ltd (India) among others.